内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2020 台湾专家共识：糖尿病黄斑水肿的管理

2020-04-28 中国眼科相关专家组（统称） Jpn J Ophthalmol. 2020 Apr 28.

糖尿病黄斑水肿

糖尿病黄斑水肿（DME）是糖尿病患者视力下降的主要原因。本文主针对DME的临床管理提供共识建议，主要内容涉及治疗目标，治疗选择，初始治疗和评估，随访安排和评估标准。

中文标题：

2020 台湾专家共识：糖尿病黄斑水肿的管理

英文标题：

Management of diabetic macular edema: experts' consensus in Taiwan.

发布机构：

中国眼科相关专家组（统称）

发布日期：

2020-04-28

简要介绍：

糖尿病黄斑水肿（DME）是糖尿病患者视力下降的主要原因。本文主针对DME的临床管理提供共识建议，主要内容涉及治疗目标，治疗选择，初始治疗和评估，随访安排和评估标准。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 台湾专家共识：糖尿病黄斑水肿的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=bed361c001900e28, title=2020 台湾专家共识：糖尿病黄斑水肿的管理, enTitle=Management of diabetic macular edema: experts' consensus in Taiwan., guiderFrom=Jpn J Ophthalmol. 2020 Apr 28., authorId=0, author=, summary=糖尿病黄斑水肿（DME）是糖尿病患者视力下降的主要原因。本文主针对DME的临床管理提供共识建议，主要内容涉及治疗目标，治疗选择，初始治疗和评估，随访安排和评估标准。, cover=https://img.medsci.cn/202055/1588682236198_2020535.jpg, journalId=0, articlesId=null, associationId=1043, associationName=中国眼科相关专家组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Tue Apr 28 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>糖尿病黄斑水肿（DME）是糖尿病患者视力下降的主要原因。本文主针对DME的临床管理提供共识建议，主要内容涉及治疗目标，治疗选择，初始治疗和评估，随访安排和评估标准。</p> </div> </div> </div>, tagList=[TagDto(tagId=216, tagName=糖尿病), TagDto(tagId=2082, tagName=黄斑水肿)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2082, guiderKeyword=黄斑水肿, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3465, appHits=182, showAppHits=41, pcHits=928, showPcHits=3332, likes=0, shares=15, comments=15, approvalStatus=1, publishedTime=Tue May 05 20:43:48 CST 2020, publishedTimeString=2020-04-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue May 05 20:37:28 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 21:03:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 台湾专家共识：糖尿病黄斑水肿的管理.pdf)])
2020 台湾专家共识：糖尿病黄斑水肿的管理.pdf
下载请点击：
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1180200, encodeId=1f34118020056, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:27:43 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064293, encodeId=28551064293ad, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=538a2114368, createdName=1871f9523em, createdTime=Wed Oct 27 09:30:35 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011906, encodeId=92c21011906b2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=538a2114368, createdName=1871f9523em, createdTime=Fri Aug 27 08:19:58 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964593, encodeId=17a39645936f, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6d25293791, createdName=1486c135m42(暂无昵称), createdTime=Tue May 11 14:53:12 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948296, encodeId=7be5948296d1, content=想下载下来好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/20/b8e58eb89b8b0dfb34af115320150086.jpg, createdBy=cd072167310, createdName=Lynn4387, createdTime=Mon Mar 15 10:25:29 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2022-01-03 ms3000000727805956

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1180200, encodeId=1f34118020056, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:27:43 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064293, encodeId=28551064293ad, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=538a2114368, createdName=1871f9523em, createdTime=Wed Oct 27 09:30:35 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011906, encodeId=92c21011906b2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=538a2114368, createdName=1871f9523em, createdTime=Fri Aug 27 08:19:58 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964593, encodeId=17a39645936f, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6d25293791, createdName=1486c135m42(暂无昵称), createdTime=Tue May 11 14:53:12 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948296, encodeId=7be5948296d1, content=想下载下来好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/20/b8e58eb89b8b0dfb34af115320150086.jpg, createdBy=cd072167310, createdName=Lynn4387, createdTime=Mon Mar 15 10:25:29 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2021-10-27 1871f9523em

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1180200, encodeId=1f34118020056, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:27:43 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064293, encodeId=28551064293ad, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=538a2114368, createdName=1871f9523em, createdTime=Wed Oct 27 09:30:35 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011906, encodeId=92c21011906b2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=538a2114368, createdName=1871f9523em, createdTime=Fri Aug 27 08:19:58 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964593, encodeId=17a39645936f, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6d25293791, createdName=1486c135m42(暂无昵称), createdTime=Tue May 11 14:53:12 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948296, encodeId=7be5948296d1, content=想下载下来好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/20/b8e58eb89b8b0dfb34af115320150086.jpg, createdBy=cd072167310, createdName=Lynn4387, createdTime=Mon Mar 15 10:25:29 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2021-08-27 1871f9523em

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1180200, encodeId=1f34118020056, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:27:43 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064293, encodeId=28551064293ad, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=538a2114368, createdName=1871f9523em, createdTime=Wed Oct 27 09:30:35 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011906, encodeId=92c21011906b2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=538a2114368, createdName=1871f9523em, createdTime=Fri Aug 27 08:19:58 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964593, encodeId=17a39645936f, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6d25293791, createdName=1486c135m42(暂无昵称), createdTime=Tue May 11 14:53:12 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948296, encodeId=7be5948296d1, content=想下载下来好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/20/b8e58eb89b8b0dfb34af115320150086.jpg, createdBy=cd072167310, createdName=Lynn4387, createdTime=Mon Mar 15 10:25:29 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2021-05-11 1486c135m42(暂无昵称)

    好好学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1180200, encodeId=1f34118020056, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:27:43 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064293, encodeId=28551064293ad, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=538a2114368, createdName=1871f9523em, createdTime=Wed Oct 27 09:30:35 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011906, encodeId=92c21011906b2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=538a2114368, createdName=1871f9523em, createdTime=Fri Aug 27 08:19:58 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964593, encodeId=17a39645936f, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6d25293791, createdName=1486c135m42(暂无昵称), createdTime=Tue May 11 14:53:12 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948296, encodeId=7be5948296d1, content=想下载下来好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/20/b8e58eb89b8b0dfb34af115320150086.jpg, createdBy=cd072167310, createdName=Lynn4387, createdTime=Mon Mar 15 10:25:29 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2021-03-15 Lynn4387

    想下载下来好好学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

新型冠状病毒感染合并糖尿病患者使用胰岛素的专家建议

中国研究型医院学会(CRHA,Chinese Research Hospital Association) · 2020-03-30

2020 ADA 糖尿病医学诊疗标准

美国糖尿病学会(ADA,American Diabetes Association) · 2019-12-21

2019 WMS临床实践指南：糖尿病的管理

荒野医学协会(WMS,Wilderness Medical Society) · 2019-11-18

《2019年欧洲心脏病学会和欧洲糖尿病研究学会糖尿病管理指南》解读

暂未更新 · 2019-10-30

治疗糖尿病药物及生物制品临床试验指导原则

国家药品监督管理局药品审评中心（CDE） · 2019-10-31

中国专家共识：糖尿病患者骨折风险管理（英文版）

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2019-06-20